This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer

Friday, July 10, 2020

Submitted by


Source Name: The Annals of Thoracic Surgery


Rhami Khorfan, Timothy J. Kruser, Julia M. Coughlin, Ankit Bharat, Karl Y. Bilimoria, David D. Odell

The authors examined The National Cancer Database for patients who refused recommended surgery and elected stereotactic body radiation therapy (SBRT) for stage I/II non-small cell lung cancer. 

Add comment

Log in or register to post comments